Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A three-way incomplete block crossover study to investigate the 24-hour pulmonary function of three dosage strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder vs. Placebo, in subjects with Chronic Obstructive Pulmonary Disease (COPD)
vilanterol
HZC110946
NCT01072149
Pulmonary Disease, Chronic Obstructive
Phase 3
 
September 2013

Powered by ideaPoint, Inc.